The effectiveness of video-assisted thoracoscopic sanitation of the pleural cavity in combination with local proteolytic therapy in children with acute pleural empyema

Abstract

BACKGROUND: A positive experience of the local applicationof proteolytic enzymes for treating purulent-inflammatory processes of various localizations has motivated the researchers to study this challenging topic and to assess the effectiveness of proteolytic enzymes in combination with video thoracoscopic sanitation and ultrasonic cavitation of the lungs and pleural cavity in children with acute pleural empyema.

AIM: To assess the effectiveness of complex treatment of acute pleural empyema in children.

METHODS: In 2020–2022, 26 children, aged 1–17 (15 boys, 57.7% and 11 girls, 42.3%), were under observation. All children were operated on for video thoracoscopic sanitation of the pleural cavity and ultrasonic cavitation of the lungs and pleural cavity. Patients were divided into two groups: main group — 12 (46.2%) children who were injected proteolytic enzymes into their pleural cavity intraoperatively and at the postoperative period; control group — 14 (53.8%) children who had no any proteolytic enzyme injections. The developed technique (Method for the treatment of acute pleural empyema in children, Patent RU2770663) was used at the surgical intervention.

RESULTS: The results obtained by the identified criteria have shown that proteolytic enzymes applied perioperatively is an effective technique what was confirmed by X-ray findings: fibrinothorax regression in the main group occurred earlier than in the control group by (2±0.4) days.

CONCLUSION: Thus, we consider that proteolytic enzymes used intraoperatively and at the early postoperative period in combination with video thoracoscopic sanitation and ultrasound cavitation of the lungs and pleural cavity is a promising and effective method for treating acute pleural empyema and can be recommended for implementation into clinical practice.

Keywords

acute pleural empyema / videothoracoscopy / ultrasonic cavitation / proteolytic enzymes

References

[1] Pritulo LF. Particular issues of acute purulent destructive pneumonia in children. Tavricheskiy mediko-biologicheskiy vestnik. 2010;13(4):138−143. (In Russ).

[2] Притуло Л.Ф. Частные вопросы острой гнойной деструктивной пневмонии у детей // Таврический медико-биологический вестник. 2010. Т. 13, № 4. С. 138−143.

[3] Rokitsky MR. Surgical diseases of the lungs in children. Leningrad: Medicine; 1988. 286 р. (In Russ).

[4] Рокицкий М.Р. Хирургические заболевания лёгких у детей. Ленинград: Медицина, 1988. 286 с.

[5] Razumovsky AY, Allaberganov KO, Alkhasov AB. Video-assisted thoracoscopic surgery for the bullous form of purulent-inflammatory lung diseases in children. Russian Journal of Pediatric Surgery. 2005;(4):46−47. (In Russ).

[6] Разумовский А.Ю., Аллаберганов К.О., Алхасов А.Б. Видеоторакоскопические операции при буллезной форме гнойно- воспалительных заболеваний лёгких у детей // Детская хирургия. Журнал им. Ю.Ф. Исакова. 2005. № 4. С. 46−47.

[7] Krenke K, Sadowy E, Podsiadły E, et al. Etiology of parapneumonic effusion and pleural empyema in children. The role of conventional and molecular microbiological tests. Respir Med. 2016;(116):28–33. doi: 10.1016/j.rmed.2016.05.009

[8] Krenke K., Sadowy E., Podsiadły E., et al. Etiology of parapneumonic effusion and pleural empyema in children. The role of conventional and molecular microbiological tests // Respir Med. 2016. N 116. Р. 28–33. doi: 10.1016/j.rmed.2016.05.009

[9] Barova NK, Tarakanov VA, Ubilava IA, Eredzhibokova MYu. Complex therapy, rehabilitation in the treatment of acute destructive pneumonia in children. Russ J Pediat Surg Anesthesia Intensive Care. 2020;10(S):29. EDN: SOALDD

[10] Барова Н.К., Тараканов В.А., Убилава И.А., Ереджибокова М.Ю. Комплексная терапия, реабилитация в лечении острой деструктивной пневмонии у детей // Российский вестник детской хирургии, анестезиологии и реаниматологии. 2020. Т. 10, № S. С. 29. EDN: SOALDD

[11] Livingston MH, Mahant S, Connolly B, et al. Effectiveness of intrapleural tissue plasminogen activator and dornase alfa vs tissue plasminogen activator alone in children with pleural empyema: A randomized clinical trial. JAMA Pediatr. 2020;174(4):332–340. doi: 10.1001/jamapediatrics.2019.5863

[12] Livingston M.H., Mahant S., Connolly B., et al. Effectiveness of intrapleural tissue plasminogen activator and dornase alfa vs tissue plasminogen activator alone in children with pleural empyema: A randomized clinical trial // JAMA Pediatr. 2020. Vol. 174, N 4. Р. 332–340. doi: 10.1001/jamapediatrics.2019.5863

[13] Domej W, Wenisch C, Demel U, Tilz GP. Vom pneumonischen Infiltrat zum parapneumonischen Erguss--vom Erguss zum Pleuraempyem: Internistische Aspekte parapneumonischer Ergussbildung und des Pleuraempyems. Wien Med Wochenschr. 2003;153(15-16):349−353. doi: 10.1007/s10354-003-0008-1

[14] Domej W., Wenisch C., Demel U., Tilz G.P. Vom pneumonischen Infiltrat zum parapneumonischen Erguss--vom Erguss zum Pleuraempyem: Internistische Aspekte parapneumonischer Ergussbildung und des Pleuraempyems // Wien Med Wochenschr. 2003. Vol. 153, N 15-16. Р. 349−353. doi: 10.1007/s10354-003-0008-1

[15] Fedotova MA, Egiev IK. The method of combination of vat sanitation and the using of proteolytic enzymes in treatment of acute pleural empyema in children. Forcipe. 2022;5(S1):18. EDN: DAZZWM

[16] Федотова М.А., Егиев И.Х. Метод комбинации видеоторакоскопической санации и местного применения протеолитических ферментов при лечении острой эмпиемы плевры у детей // Forcipe. 2022. Т. 5, № S1. С. 188. EDN: DAZZWM

[17] Arnold DT, Hamilton FW, Elvers KT, et al. Pleural fluid super levels predict the need for invasive management in parapneumonic effusions. Am J Respir Crit Care Med. 2020;201(12):1545−1553. doi: 10.1164/rccm.201911-2169OC

[18] Arnold D.T., Hamilton F.W., Elvers K.T., et al. Pleural fluid super levels predict the need for invasive management in parapneumonic effusions // Am J Respir Crit Care Med. 2020. Vol. 201, N 12. Р. 1545−1553. doi: 10.1164/rccm.201911-2169OC

[19] Khasanov RR, Gumerov AA, Mamleev IA, Sataev VU. Economic efficacy of thoracoscopic treatment for pleural empyema in children. N.I. Pirogov J Surg. 2009;(11):42–47. EDN: LBEJNL

[20] Хасанов Р. Р., Гумеров А. А., Мамлеев И. А., Сатаев В.У. Экономическая эффективность лечения эмпиемы плевры с применением торакоскопии у детей // Хирургия. 2009. № 11. С. 42–47. EDN: LBEJNL

[21] Barova NK, Tarakanov VA, Cipris AA, et al. The modern medical technologies for treatment of acute destructive pneumonia in children. Kuban Sci Med Bulletin. 2013;(7):58−59. EDN: RSKHIJ

[22] Барова Н.К., Тараканов В.А., Циприс А.А., и др. Современные медицинские технологии в лечении острой деструктивной пневмонии у детей // Кубанский научный медицинский вестник. 2013. № 7. С. 58−59. EDN: RSKHIJ

[23] Kashin AS, Mamleev IA, Sataev VU, et al. Diagnostics and thoracoscopic treatment of pleural empyema in younger children. N.I. Pirogov J Surg. 2009;(11):38−41 EDN: LBEJMR

[24] Кашин А.С., Мамлеев И.А., Сатаев В.У., и др. Диагностика и лечение эмпиемы плевры с применением торакоскопии у детей // Хирургия. Журнал им. Н.И. Пирогова. 2009. № 11. С. 38−41. EDN: LBEJMR

[25] Balfour-Lynn IM, Abrahamson E, Cohen G, et al. BTS guidelines for the management of pleural infection in children. Thorax. 2005;60(Suppl 1):11–21. doi: 10.1136/thx.2004.030676

[26] Balfour-Lynn I.M., Abrahamson E., Cohen G., et al. BTS guidelines for the management of pleural infection in children // Thorax. 2005. Vol. 60, Suppl. 1. Р. i1−21. doi: 10.1136/thx.2004.030676

[27] Egiev IKh, Tarakanov VA, Barova NK, Ubilava IA. Surgical treatment of acute pleural empyema in children using the method of combination of videothoracoscopic sanation and local application of proteolytic enzymes. Russ J Pediatr Surg Anesthesia Intensive Care. 2022;12(S):56. EDN: VQYABV

[28] Егиев И.Х., Тараканов В.А., Барова Н.К., Убилава И.А. Хирургическое лечение острой эмпиемы плевры у детей с применением метода комбинации видеоторакоскопической санации и местного применения протеолитических ферментов // Российский вестник детской хирургии, анестезиологии и реаниматологии. 2022. Т. 12, № S. С. 56. EDN: VQYABV

[29] Razumovsky AY, Allaberganov KO, Alkhasov AB. Thoracoscopic surgeries for complicated forms of purulent inflammatory lung diseases in children. Ann Surg. 2006;(6):43−45. (In Russ).

[30] Разумовский А.Ю., Аллаберганов К.О., Алхасов А.Б. Торакоскопические операции при осложненных формах ГВЗЛ у детей // Анналы хирургии. 2006. № 6. С. 43−45.

[31] Altmann ES, Crossingham I, Wilson S, Davies HR. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema. Cochrane Database Syst Rev. 2019.2019;(10):CD002312. doi: 10.1002/14651858.CD002312.pub4

[32] Altmann E.S., Crossingham I., Wilson S., Davies H.R. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema // Cochrane Database Syst Rev. 2019. Vol. 2019, N 10. Р. CD002312. doi: 10.1002/14651858.CD002312.pub4

[33] Singh G, Pitoyo CW, Nasir AU, et al. Update on the role of intrapleural fibrinolytic therapy in the management of complicated parapneumonic effusions and empyema. Acta Med Indones. 2012;44(3):258−264.

[34] Singh G., Pitoyo C.W., Nasir A.U., et al. Update on the role of intrapleural fibrinolytic therapy in the management of complicated parapneumonic effusions and empyema // Acta Med Indones. 2012. Vol. 44, N 3. Р. 258−264.

[35] Majid A, Ochoa S, Chatterji S, et al. Safety and efficacy of tissue plasminogen activator and DNase for complicated pleural effusions secondary to abdominal pathology. Ann Am Thorac Soc. 2017;14(3):342−346. doi: 10.1513/AnnalsATS.201608-594BC

[36] Majid A., Ochoa S., Chatterji S., et al. Safety and efficacy of tissue plasminogen activator and DNase for complicated pleural effusions secondary to abdominal pathology // Ann Am Thorac Soc. 2017. Vol. 14, N 3. Р. 342−346. doi: 10.1513/AnnalsATS.201608-594BC

[37] Scharm SC, Dettmer S. Erkrankungen der Pleura, der Thoraxwand und des Zwerchfells. Radiologe. 2022;62(2):91−98. doi: 10.1007/s00117-021-00958-5

[38] Scharm S.C., Dettmer S. Erkrankungen der Pleura, der Thoraxwand und des Zwerchfells // Radiologe. 2022. Vol. 62, N 2. Р. 91−98. doi: 10.1007/s00117-021-00958-5

[39] Bataev SM, Ignatyev RO, Zurbaev NT, et al. Hydrosurgical technology in the treatment of a child with complicated pneumonia secondary to scarlet fever. Pediatriya: Zhurnal imeni G.N. Speranskogo. 2018;97(2):113−117. EDN: YTCBBG doi: 10.24110/0031-403X-2018-97-2-113-117

[40] Батаев С.М., Игнатьев Р.О., Зурбаев Н.Т., и др. Применение гидрохирургической технологии в лечении ребенка с осложненной пневмонией на фоне скарлатины // Педиатрия. Журнал имени Г.Н. Сперанского. 2018. Т 97, № 2. С. 113−117. EDN: YTCBBG doi: 10.24110/0031-403X-2018-97-2-113-117

[41] Merry C.M., Bufo A.J., Shah R.S. Early defi nitive intervention by thoracoscopy in pediatric empyema. J Pediatr Surg. 1999;34:178–181.

[42] Merry C.M., Bufo A.J., Shah R.S. Early defi nitive intervention by thoracoscopy in pediatric empyema. J Pediatr Surg 1999.Vol. 34. Р. 178—181

[43] Kashin AS, Mamleev IA, Sataev VU, et al. Thoracoscopic treatment of pulmonary-pleural complications of acute necrotizing pneumonia in new born and infants. Children's Med North-West. 2012;3(4):23−28. EDN: RUESSR

[44] Кашин А.С., Мамлеев И.А., Сатаев В.У., и др. Торакоскопическое лечение легочно-плевральных осложнений острой деструктивной пневмонии у новорожденных и детей раннего возраста // Детская медицина Северо-Запада. 2012. Т. 3, № 4. С. 23−28. EDN: RUESSR

[45] Amarantov D.G. Programmed staged thoracoscopy in the treatment of patients with acute para- and metapneumonic pleural empyema [dissertation abstract]. Saratov, 2005. 21 p. (In Russ.)"

[46] Амарантов Д.Г. Программированные этапные торакоскопии в лечении больных с острой пара- и метапневмонической эмпиемой плевры: автореф. дис. ... кандидат медицинских наук. Саратов, 2005. 21 с.

[47] Bataev SM, Zurbaev NT, Molotov RS, et al. The first experience of the use of hydro-surgical technologies in the treatment of children with pulmatic-pleural complications of destructive pneumonia. N.I. Pirogov J Surg. 2019;(7):15−23. EDN: AMMQBC doi: 10.17116/hirurgia201907115

[48] Батаев С.М., Зурбаев Н.Т., Молотов Р.С., и др. Первый опыт применения гидрохирургических технологий в лечении детей с легочно-плевральными осложнениями деструктивной пневмонии // Хирургия. Журнал им. Н.И. Пирогова. 2019. № 7. С. 15−23. EDN: AMMQBC doi: 10.17116/hirurgia201907115

[49] Knisely BL, Broderick LS, Kuhlman JE. MR imaging of the pleura and chest wall. Magn Reson Imaging Clin N Am. 2000;8(1):125−141.

[50] Knisely B.L., Broderick L.S., Kuhlman J.E. MR imaging of the pleura and chest wall // Magn Reson Imaging Clin N Am. 2000. Vol. 8, N 1. Р. 125−141.

[51] Ravaglia C, Gurioli C, Tomassetti S, et al. Is medical thoracoscopy efficient in the management of multiloculated and organized thoracic empyema? Respiration. 2012;84(3):219−224. doi: 10.1159/000339414

[52] Ravaglia C., Gurioli C., Tomassetti S., et al. Is medical thoracoscopy efficient in the management of multiloculated and organized thoracic empyema? // Respiration. 2012. Vol. 84, N 3. Р. 219−224. doi: 10.1159/000339414

[53] Tassi GF, Marchetti GP, Pinelli V, Chiari S. Practical management of pleural empyema. Monaldi Arch Chest Dis. 2010;73(3):124−129. doi: 10.4081/monaldi.2010.296

[54] Tassi G.F., Marchetti G.P., Pinelli V., Chiari S. Practical management of pleural empyema // Monaldi Arch Chest Dis. 2010. Vol. 73, N 3. Р. 124−129. doi: 10.4081/monaldi.2010.296

RIGHTS & PERMISSIONS

Barova N.K., Egiev I.K., Grigorova A.N., Ubilava I.A., Stryukovsky A.E., Nadgeriev V.M., Starchenko V.M.